Amphenol posts 58% Q1 sales growth, strong Q2 outlook despite high valuation concerns

Amphenol reported a strong Q1 with sales up 58% and organic growth at 33%, driven by successful mergers and acquisitions. The company projects Q2 sales growth of 43-45% and adjusted earnings per share between $1.14 and $1.16, indicating continued momentum. Despite robust operational performance and margin expansion, Amphenol's stock trades at a relatively high valuation of around 30 times forward earnings, suggesting cautious investor expectations. The company maintains a manageable net debt of $14.2 billion with leverage below 2x EBITDA, supported by strong earnings and disciplined capital management.